MMBG Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.08M Sell
14,105
-2,000
-12% -$960K 0.56% 32
2026
Q1
$7.92M Hold
16,105
– – 0.73% 30
2025
Q4
$9.34M Buy
16,105
+854
+6% +$483K 0.79% 27
2025
Q3
$7.4M Hold
15,251
– – 0.66% 31
2025
Q2
$6.19M Buy
15,251
+2,660
+21% +$1.11M 0.62% 32
2025
Q1
$6.27M Sell
12,591
-1,910
-13% -$1.03M 0.71% 29
2024
Q4
$7.54M Buy
14,501
+185
+1% +$102K 0.8% 26
2024
Q3
$8.86M Buy
14,316
+4,896
+52% +$2.9M 0.92% 26
2024
Q2
$5.21M Buy
9,420
+805
+9% +$461K 0.56% 38
2024
Q1
$5.01M Buy
8,615
+450
+6% +$253K 0.53% 40
2023
Q4
$4.33M Buy
8,165
+1,595
+24% +$772K 0.51% 44
2023
Q3
$3.33M Sell
6,570
-780
-11% -$416K 0.42% 49
2023
Q2
$3.75M Buy
+7,350
New +$3.97M 0.46% 48

Other funds holding TMO

MMBG Investment Advisors's TMO Position: Q2 2026 in Review

MMBG Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $960K and leaving 14,105 shares worth $7.08M. The position accounts for 0.56% of the portfolio, ranked #32.

MMBG Investment Advisors first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.34M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MMBG Investment Advisors held 14,105 shares of Thermo Fisher Scientific worth $7.08M as of Q2 2026.
  • MMBG Investment Advisors sold 2,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $960K.
  • Thermo Fisher Scientific made up 0.56% of MMBG Investment Advisors's portfolio in Q2 2026, its #32 holding.
  • MMBG Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • MMBG Investment Advisors's Thermo Fisher Scientific position peaked at $9.34M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.